SOPH
SOPHiA GENETICS SA
7.20$
-3.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -10.0% | +3.9% | -1.1% | +8.6% | +3.3% | +0.4% | +3.2% | +2.3% | +0.6% | +12.8% | +5.7% | – | |
| – | +7.0% | -11.7% | +9.9% | -11.5% | +40.5% | -24.5% | +13.6% | -4.8% | -6.7% | -14.3% | +35.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -136.4% | – | – | -185.8% | – | – | -46.4% | +171.6% | -166.5% | – | – | |
| – | +7.0% | -12.9% | -0.1% | +18.6% | -16.4% | -23.1% | +32.5% | -94.6% | +228.7% | +152.0% | +207.2% | – | |
| – | +7.0% | -55.3% | +10.9% | +269.1% | -52.9% | -46.4% | +49.4% | +66.0% | +52.5% | -26.9% | -14.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -8.6% | -23.8% | – | -101.5% | -5.7% | +19.3% | +11.1% | – | |
| – | -33.2% | +46.8% | – | -100.2% | +2,628.6% | +72.8% | – | -105.9% | – | +3,525.2% | +275.2% | – | |
| – | – | – | – | -678.5% | – | – | – | -150.2% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.